EIX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Edison International (EIX) does not present a compelling buy opportunity for a beginner, long-term investor at this time. While the company has shown strong financial performance in the latest quarter and hedge funds are increasing their positions, the technical indicators suggest the stock is overbought, and analyst ratings are mixed with limited upside potential. Additionally, the options data indicates a bearish sentiment in open interest. Given these factors, it is better to hold off on investing until a more favorable entry point arises.
The technical indicators show a bullish trend with MACD positively expanding and moving averages indicating upward momentum (SMA_5 > SMA_20 > SMA_200). However, the RSI at 89.42 indicates the stock is overbought, suggesting limited short-term upside potential. The stock is trading near its resistance levels (R1: 68.233, R2: 70.383), which could act as barriers to further price increases.
Hedge funds are significantly increasing their positions, with a 2302.48% increase in buying over the last quarter.
Strong financial performance in Q3 2025, with revenue up 10.56% YoY, net income up 61.24% YoY, and EPS up 63.64% YoY.
Investors are favoring high dividend-yielding utility stocks amid market turbulence, which could support EIX's price.
Analysts' ratings are mixed, with recent downgrades and price target reductions.
The stock is overbought based on RSI, indicating a potential pullback.
Options data shows bearish sentiment with a high Open Interest Put-Call Ratio.
No recent congress trading data or significant insider activity to support the stock.
Edison International reported strong financials in Q3 2025, with revenue increasing to $5.75 billion (up 10.56% YoY), net income rising to $832 million (up 61.24% YoY), and EPS improving to 2.16 (up 63.64% YoY). Gross margin also increased to 55.43%, up 11.17% YoY, indicating improved profitability.
Analyst ratings are mixed. JPMorgan raised its price target to $66 but maintained a Neutral rating. Barclays lowered its price target to $67 but kept an Overweight rating. Morgan Stanley raised its price target to $61 but maintained an Underweight rating. The consensus reflects limited upside potential and cautious sentiment among analysts.
